2016 Annual Meeting of the American Association for the Study of Liver Diseases*

November 11-15, 2016; Boston, Massachusetts
Examine Capsule Summaries, download slides, and review analysis by expert faculty on key studies from Boston 2016.
Ira M. Jacobson, MD
Brent A. Neuschwander-Tetri, MD
Mark S. Sulkowski, MD
Stefan Zeuzem, MD


Listen to a rapid review of the key hepatology studies from Boston 2016 expected to affect clinical practice, followed by expert answers to participants’ questions.

Released: November 28, 2016

In this Expert Analysis, Ira M. Jacobson, MD, and Stefan Zeuzem, MD, provide expert interpretation of the most clinically important new data on HCV, HBV, and NASH from this important annual conference.

Ira M. Jacobson, MD Stefan Zeuzem, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: February 1, 2017 Expired: No longer available for credit

In this downloadable slideset, expert faculty members Ira M. Jacobson, MD, and Stefan Zeuzem, MD, summarize key studies from this important annual conference.

Released: November 30, 2016


The 2016 hepatology meeting in Boston offered future solutions to some of my most vexing patient challenges.

Mark S. Sulkowski, MD Released: January 31, 2017

The treatment of NASH has challenges not seen in patients with HCV infection, but new trends are emerging.

Brent A. Neuschwander-Tetri, MD Released: March 10, 2017
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Educational grant provided by:
Merck & Co., Inc.
Gilead Sciences

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.